Conter Mauro, Paludi Domenico, Zanardi Emanuela, Ghidini Sergio, Vergara Alberto, Ianieri Adriana
Department of Animal Production, Veterinary Biotechnologies, Food Quality and Safety, Parma University, 43100 Parma, Italy.
Int J Food Microbiol. 2009 Jan 15;128(3):497-500. doi: 10.1016/j.ijfoodmicro.2008.10.018. Epub 2008 Oct 28.
The objective of this study was to evaluate the susceptibility of 120 Listeria monocytogenes strains isolated from food and food-processing environments to 19 antibiotics currently used in veterinary and human therapy. Susceptibility tests were performed by using the automated VITEK2 system. Apart from penicillin, ampicillin and trimethoprim-sulfamethoxazole, for which clinical breakpoints for Listeria susceptibility testing are defined according to the Clinical and Laboratory Standard Institute (CLSI), in the present study the CLSI criteria for staphylococci were applied. Among the 120 tested strains, 14 (11.7%) displayed resistance to at least one antibiotic. In particular, resistance to one antibiotic was more common than multiple resistance, i.e., 10 (8.3%) isolates were resistant to one antibiotic, 3 (2.5%) to two antibiotics and one (0.8%) to five antibiotics. Resistance to clindamycin was the most common, followed by linezolid, ciprofloxacin, ampicillin and rifampicin, trimethoprim/sulphamethoxazole and, finally, vancomycin and tetracycline. This study shows that L. monocytogenes strains from food and food-processing environments are susceptible to the antibiotics commonly used in veterinary and human listeriosis treatment. Considering that L. monocytogenes is slowly becoming antibiotic resistant, a continued surveillance of emerging antimicrobial resistance of this pathogen is important to ensure effective treatment of human listeriosis. These data are useful in improving background data on antibiotic resistance of strains isolated from food and food environment.
本研究的目的是评估从食品和食品加工环境中分离出的120株单核细胞增生李斯特菌菌株对目前兽用和人用治疗中使用的19种抗生素的敏感性。使用自动化VITEK2系统进行药敏试验。除了青霉素、氨苄西林和甲氧苄啶-磺胺甲恶唑(针对这些抗生素,根据临床和实验室标准协会(CLSI)定义了李斯特菌药敏试验的临床断点)外,本研究采用了CLSI针对葡萄球菌的标准。在120株受试菌株中,14株(11.7%)对至少一种抗生素耐药。特别是,对一种抗生素的耐药比多重耐药更常见,即10株(8.3%)分离株对一种抗生素耐药,3株(2.5%)对两种抗生素耐药,1株(0.8%)对五种抗生素耐药。对克林霉素的耐药最为常见,其次是利奈唑胺、环丙沙星、氨苄西林和利福平、甲氧苄啶/磺胺甲恶唑,最后是万古霉素和四环素。本研究表明,来自食品和食品加工环境的单核细胞增生李斯特菌菌株对兽用和人用李斯特菌病治疗中常用的抗生素敏感。鉴于单核细胞增生李斯特菌正逐渐产生抗生素耐药性,持续监测该病原体新出现的抗菌耐药性对于确保有效治疗人类李斯特菌病很重要。这些数据有助于完善从食品和食品环境中分离出的菌株的抗生素耐药性背景数据。